Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Bispectral Index Monitoring on Recovery From Deep Sedation

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 3-12 years old children with spastic cerebral palsy receiving botulinum toxin injection with deep sedation~* American Society of Anesthesiologists Physical Status 1-2~Exclusion Criteria:~* Body mass index \> 30 kg/m2~* unstable heart disease~* Anticipated difficult airway including congenital facial or airway anomaly~* Recent upper respiratory tract infection ( \< 2 weeks)~* Gastroesophageal reflux~* Allergy history to propofol, remifentanil or any drug used during procedure

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Group Control (Type: None): Group who maintains deep sedation using the University of Michigan sedation scale (UMSS) score.
- Group BIS (Type: None): Group who maintain deep sedation using Bispectral Index (BIS) score.

Based on this trial design, predict the completion outcome and termination type (if applicable).